Deep Pathomic Learning Defines Prognostic Subtypes and Molecular Drivers in Colorectal Cancer
PositiveArtificial Intelligence
- The TDAM
- This development is crucial for personalized medicine, as it provides more accurate risk stratification and identifies novel biomarkers that can guide treatment decisions for CRC patients.
- The ongoing evolution of machine learning applications in cancer detection and prognosis highlights a broader trend towards integrating advanced technologies in healthcare, aiming to improve early detection and treatment outcomes across various cancer types.
— via World Pulse Now AI Editorial System
